Carregant...

Brand and Generics Companies Unite to Pressure FDA: They Want the Agency to Drop Its Safety-Label Plan and Adopt Their Alternative

Fear of lawsuits and customer confusion have greeted a Food and Drug Administration plan to let generic drug companies change labels quickly, without prior agency approval, when they learn of adverse effects once the generic reaches the market.

Guardat en:
Dades bibliogràfiques
Publicat a:P T
Autor principal: Barlas, Stephen
Format: Artigo
Idioma:Inglês
Publicat: MediMedia USA, Inc. 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4517532/
https://ncbi.nlm.nih.gov/pubmed/26236138
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!